Press Releases Akari Therapeutics, Plc

Equities

AKTX

US00972G2075

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
1.185 ^USD	-0.42%		+1.61%	-62.02%

Apr. 24	European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	MT
Apr. 23	European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography Data at ARVO 2024	Apr. 16	AQ
Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024	Apr. 15	AQ
Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights	Apr. 01	AQ
AKTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Akari Therapeutics, Plc Is Fair to Shareholders	Mar. 05	BU
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit	Mar. 05	AQ
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit	Mar. 05	AQ
Akari Therapeutics Announces Existing Investors Support the Company through a $2 Million Private Placement Financing	Jan. 03	AQ
Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing	Jan. 02	AQ
Akari Therapeutics to Present at Biotech Showcase 2024	Dec. 14	AQ
Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors	Dec. 04	AQ
Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors	Dec. 01	AQ
Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy	Nov. 17	AQ
Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference	Nov. 16	AQ
Akari Therapeutics : BioFuture Company Presentation	Nov. 06	PU
Akari Therapeutics to Present a Poster on Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference	Nov. 06	AQ
Akari Therapeutics Reports First Half 2023 Financial Results and Highlights	23-10-02	AQ
Akari Therapeutics Reports First Half 2023 Financial Results and Highlights	23-09-29	AQ
Akari Therapeutics to Present at Emerging Growth Conference	23-09-27	AQ
Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing, Company Also Receives $2.5 Million U.K. R&D Tax Credit	23-09-21	AQ
Akari Therapeutics to Host Key Opinion Leader Webinar on Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy and the Potential of Nomacopan to Address Significant Unmet Needs	23-09-20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Akari Therapeutics, Plc

Equities

AKTX

US00972G2075

Press Releases

Filters